Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	459	355	112	71	106	197
Market Cap Growth	352.13%	215.68%	57.54%	-32.42%	-46.38%	53.54%
Enterprise Value	464	339	96	64	90	197
Last Close Price	17.12	13.32	4.38	2.82	4.29	8.13
Forward PE	23.85	57.91	79.64	-	9.98	-
PS Ratio	7.78	9.09	3.55	3.36	4.84	5047.59
PB Ratio	19.16	14.52	7.26	5.46	5.99	12.57
P/TBV Ratio	-	-	10.47	8.57	7.54	13.05
P/FCF Ratio	37.56	376.22	16.49	14.92	-	-
P/OCF Ratio	37.52	366.13	16.49	14.80	-	-
EV/Sales Ratio	7.98	8.69	3.04	3.03	4.11	5040.62
EV/FCF Ratio	37.99	359.32	14.11	13.46	-	-
Debt / Equity Ratio	1.28	1.23	0.35	0.50	0.38	0.46
Debt / FCF Ratio	2.51	31.81	0.80	1.36	-	-
Asset Turnover	0.87	0.72	1.12	0.81	0.81	0.00
Inventory Turnover	1.65	1.93	14.42	12.53	3.16	0.54
Quick Ratio	1.03	1.02	1.53	2.81	4.36	5.63
Current Ratio	1.77	2.06	1.65	3.10	5.18	6.51
Return on Equity (ROE)	-22.06%	-19.16%	-6.56%	-58.75%	-11.74%	-213.40%
Return on Assets (ROA)	1.83%	-2.53%	-2.63%	-19.67%	-3.47%	-78.10%
Return on Capital (ROIC)	3.35%	-3.62%	-3.68%	-23.51%	-3.96%	-89.38%
Earnings Yield	-0.90%	-1.08%	-0.83%	-12.65%	-1.85%	-14.21%
FCF Yield	2.66%	0.27%	6.06%	6.71%	-4.48%	-11.38%
Buyback Yield / Dilution	-2.73%	-0.97%	-1.99%	0.24%	-19.98%	-18.30%

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q